Donepezil-related toxic hepatitis

Acta Clinica Belgica

Volumn 63, Issue 5, 2008, Pages 339-342

  Dierckx, R I R ^a   Vandewoude, M F J ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ZNA St Elisabeth   (Belgium)

Author keywords

Alzheimer's disease; Cholinesterase inhibitor; Donepezil; Hepatotoxicity; Jaundice

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BILIRUBIN; BISOPROLOL; BUMETANIDE; CHOLINESTERASE INHIBITOR; DONEPEZIL; INSULIN; LISINOPRIL; MITOCHONDRION ANTIBODY;

ABDOMINAL PAIN; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; CHOLINERGIC SYSTEM; CLINICAL ASSESSMENT; COGNITIVE DEFECT; DRUG WITHDRAWAL; ECHOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER PARENCHYMA; MALE; MINI MENTAL STATE EXAMINATION; NAUSEA; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SENILE PLAQUE; TOXIC HEPATITIS; VOMITING;

EID: 57049141000     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2008.066     Document Type: Article

References (5)

1. Shintani EY, Uchida KM. Donepezil: an anticholinesterase inhibitor for Alzheimer's disease. Am J Health Syst Pharm 1997; 54: 2805-10.
2. Verrico MM, Nace DA, Towers AL. Fulminant chemical hepatitis possibly associated with donepezil and sertraline therapy. J Am Geriatr Soc 2000; 48: 1659-63.
3. Prescott LF. Hepatotoxicity of mild analgesics. Br J Clin Pharmacol 1980; 10: 373S-9S.
4. Hagley MT, Hulisz DT, Burns CM. Hepatotoxicity associated with angiotensin-converting enzyme inhibitors. Ann Pharmacother 1993; 27: 228-31.
5. Maria VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 663-9.